PharmaSources.com (http://www.PharmaSources.com/news) is the initiator of the original writers league in the pharmaceutical industry. Our goal is to provide users with up-to-date, professional and in-depth industry reports on a daily basis, to achieve effective sharing of information among pharmaceutical professionals and together to witness the development of pharmaceutical industry.
What we can provide:
An opportunity to become KOL in the pharmaceutical industry
First release and exclusive rights for PharmaSources.com
Need to be punctual and always meet the deadline.
If you are an expert in Pharma, if you have passions for writing in spare time, join us to share your insights into the hot news, market analysis, research and development of the pharmaceutical industry!
NMPA announced the emergency drug review and approval, and conditionally approved the first-in-class innovative drugs, Simnotrelvir Tablets/Ritonavir Tablets of Hainan Simcere Pharmaceutical and Renmindevir of Shanghai Wangshi Biological Technology.